Skip to main content
Log in

A sugar sweet new treatment for erectile dysfunction after radical prostatectomy

  • Comment
  • Published:
International Journal of Impotence Research Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Weyne E, Mulhall J, Albersen M. Molecular pathophysiology of cavernous nerve injury and identification of strategies for nerve function recovery after radical prostatectomy. Curr Drug Targets. 2015;16:459–73.

    Article  CAS  Google Scholar 

  2. Aliperti LA, Lasker GF, Hagan SS, Hellstrom JA, Gokce A, Trost LW, et al. Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury. Urology. 2014;84:1122–7.

    Article  Google Scholar 

  3. Heidenberg DJ, Haney NM, Rezk BM, Talwar S, Okpechi SC, Srivastav SK, et al. Pioglitazone’s beneficial effects on erectile function preservation after cavernosal nerve injury in the rat are negated by inhibition of the insulin-like growth factor-1 receptor: a preclinical study. IJIR. 2018: 1–22. https://doi.org/10.1038/s41443-018-0054-2.

  4. Understanding unapproved use of approved drugs “off label”. Available at: https://www.fda.gov/forpatients/other/offlabel/default.htm. U.S. Food and Drug Administration. Accessed 23 July 2018.

  5. Sezen SF, Lagoda G, Burnett AL. Role of immunophilins in recovery of erectile function after cavernous nerve injury. J Sex Med. 2009;6:340–6.

    Article  CAS  Google Scholar 

  6. A safety and efficacy study of program in the prevention of erectile dysfunction after radical prostatectomy. Available at: http://clinicaltrials.gov/show/NCT00106392. Accessed 20 September 2014.

  7. Evaluate the effects of GPI 1485 on erectile function following bilateral nerve-sparing prostatectomy. Available at: http://clinicaltrials.gov/show/NCT00090376. Accessed 20 September 2014.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emmanuel Weyne.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weyne, E. A sugar sweet new treatment for erectile dysfunction after radical prostatectomy. Int J Impot Res 31, 50–51 (2019). https://doi.org/10.1038/s41443-018-0073-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-018-0073-z

  • Springer Nature Limited

Navigation